Wealth Shield Partners, LLC Edwards Lifesciences Corp Transaction History

Wealth Shield Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $342,654 - $397,034	-4,209 Reduced 17.16%	20,312 $1.92 Million
Q1 2023 May 08, 2023	BUY	$74.26 - $84.51 $1.82 Million - $2.07 Million	24,521 New	24,521 $2.03 Million
Q3 2022 Nov 04, 2022	BUY	$82.37 - $107.29 $97,196 - $126,602	1,180 Added 7.86%	16,191 $1.34 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $1.3 Million - $1.93 Million	15,011 New	15,011 $1.43 Million
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $1.21 Million - $1.52 Million	-11,850 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $207,421 - $254,826	1,950 Added 19.7%	11,850 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $972,602 - $1.16 Million	9,451 Added 2104.9%	9,900 $1.12 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $37,644 - $47,037	449 New	449 $47,000
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $409,529 - $471,937	-5,205 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $65,237 - $83,019	910 Added 21.19%	5,205 $474,000
Q3 2020 Oct 30, 2020	BUY	$67.19 - $87.44 $288,581 - $375,554	4,295 New	4,295 $343,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Shield Partners, LLC with notifications on news.